您当前的位置:
首页 >
文章列表页 >
Clinical practice guidelines for cancer-related fatigue in China (2021 edition)
更新时间:2025-12-31
    • Clinical practice guidelines for cancer-related fatigue in China (2021 edition)

    • China Oncology   Vol. 31, Issue 9, Pages: 852-872(2021)
    • DOI:10.19401/j.cnki.1007-3639.2021.09.012    

      CLC:
    • Published Online:08 October 2021

      Published:08 October 2021

    移动端阅览

  • 中华医学会肿瘤学分会肿瘤支持康复治疗学组. Clinical practice guidelines for cancer-related fatigue in China (2021 edition)[J]. China Oncology, 2021, 31(9): 852-872. DOI: 10.19401/j.cnki.1007-3639.2021.09.012.

  •  
  •  
icon
试读结束,您可以激活您的VIP账号继续阅读。
去激活 >
icon
试读结束,您可以通过登录账户,到个人中心,购买VIP会员阅读全文。
已是VIP会员?
去登录 >

0

Views

2422

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2026 edition)
Interpretation of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer: precision treatment guided by genotyping
China Anti-Cancer Association guideline for diagnosis and treatment of neuroendocrine neoplasms (2025 edition)
Practice guideline for the histopathological diagnosis of mesothelioma (2025 version)
Expert consensus of 177Lu-labeled PSMA radioligand therapy for clinical practice of prostate cancer (2024 edition)

Related Author

The Society of Breast Cancer China Anti-Cancer Association
Breast Oncology Group of the Oncology Branch of the Chinese Medical Association
Hao WANG
Jun LIANG
of Neuroendocrine Neoplasm of China Anti-Cancer Association Society
Expert Committee on Pathology of Chinese Research Hospital Association
Professional Committee on Tumor Pathology of Shanghai Anticancer Association
Nuclear Medicine Committee of China Anti-Cancer Association Cancer

Related Institution

Department of Radiotherapy, Qingdao Hospital, University of Health and Rehabilitation Science (Qingdao Municipal Hospital)
Oncology Medical Center, Peking University International Hospital
苏州大学附属第一医院,江苏省血液病研究所,国家血液系统疾病临床医学研究中心
0